Future Of Computational Biology Market

Research Nester published a report titled “Computational Biology Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers a detailed overview of the global computational biology market in terms of market segmentation by application, component, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global computational biology market is anticipated to attain a CAGR of ~20% over the forecast period, i.e., 2022 – 2031. The market is segmented by application into cellular and biological simulation, drug discovery, disease modelling, preclinical drug development, clinical trials, human body simulation, and others. 

Out of these, the drug discovery segment is anticipated to hold the notable share in the global computational biology market over the forecast period on account of growing demand for new and effective drugs, backed by the growing prevalence of diseases, and development of immunity in the microbes for a specific drug.

The global computational biology market is estimated to grow on the back of increasing research activities, along with the growing investment in the R&D activities. Computational biology is a science of studying biological systems through mathematical modelling, which is required for research activities, biotech and genomics, pharmaceutical R&D, and scientific software development. The advancement in the medical science, along with the development of innovative technologies and medical equipment is estimated to boost the market growth.

On the basis of geographical analysis, the global computational biology market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period on the back of the growing R&D activities, coupled with the high investment in research activities. According to the data by the World Bank, 2.732% of the GDP of North America was spent on R&D activities in 2018. Moreover, increasing scope for learning and practicing computational biology in the region is also estimated to boost the market growth.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). 

In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Growing Investment in R&D Activities to Boost the Market Growth

According to the data by the World Bank, 2.203% of the global gross domestic product (GDP) was spent for research and development activities in the year 2018.

Increasing research and development activities is estimated to majorly drive the market growth, as research activities require the knowledge of computational biology to study human genomes. Furthermore, the high investment in R&D activities by the government and private companies, is further estimated to boost the market growth.

However, lack of enough number of researchers and trained professionals is expected to operate as key restraint to the growth of global computational biology market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global computational biology market which includes company profiling of Certara Inc., Instem Group, Compugen, Chemical Computing Group ULC, Rhenovia Pharma SAS, Nimbus Discovery LLC, Rhenovia Pharma SAS, Insilico Biotechnology AG, Genedata AG, and Dassault Systèmes SE. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. 

On the whole, the report depicts detailed overview of the global computational biology market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.